nugent care 2019
nugent care 2019 Company Information
Company Number
12227571
Next Accounts
Dec 2025
Shareholders
-
Group Structure
View All
Industry
Other human health activities
Registered Address
99 edge lane, liverpool, merseyside, L7 2PE
Website
nugenthouse.co.uknugent care 2019 Estimated Valuation
Pomanda estimates the enterprise value of NUGENT CARE 2019 at £17.4m based on a Turnover of £21.6m and 0.8x industry multiple (adjusted for size and gross margin).
nugent care 2019 Estimated Valuation
Pomanda estimates the enterprise value of NUGENT CARE 2019 at £13.1m based on an EBITDA of £2.2m and a 5.94x industry multiple (adjusted for size and gross margin).
nugent care 2019 Estimated Valuation
Pomanda estimates the enterprise value of NUGENT CARE 2019 at £35.3m based on Net Assets of £14.4m and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Nugent Care 2019 Overview
Nugent Care 2019 is a live company located in merseyside, L7 2PE with a Companies House number of 12227571. It operates in the other human health activities sector, SIC Code 86900. Founded in September 2019, it's largest shareholder is unknown. Nugent Care 2019 is a young, large sized company, Pomanda has estimated its turnover at £21.6m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Nugent Care 2019 Health Check
Pomanda's financial health check has awarded Nugent Care 2019 a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 1 areas for improvement. Company Health Check FAQs
5 Strong
5 Regular
1 Weak
Size
annual sales of £21.6m, make it larger than the average company (£727.3k)
£21.6m - Nugent Care 2019
£727.3k - Industry AVG
Growth
3 year (CAGR) sales growth of 7%, show it is growing at a similar rate (7.2%)
7% - Nugent Care 2019
7.2% - Industry AVG
Production
with a gross margin of 38.5%, this company has a comparable cost of product (38.5%)
38.5% - Nugent Care 2019
38.5% - Industry AVG
Profitability
an operating margin of 6.6% make it more profitable than the average company (5%)
6.6% - Nugent Care 2019
5% - Industry AVG
Employees
with 483 employees, this is above the industry average (19)
483 - Nugent Care 2019
19 - Industry AVG
Pay Structure
on an average salary of £25.8k, the company has an equivalent pay structure (£26.5k)
£25.8k - Nugent Care 2019
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £44.7k, this is equally as efficient (£45.5k)
£44.7k - Nugent Care 2019
£45.5k - Industry AVG
Debtor Days
it gets paid by customers after 21 days, this is near the average (20 days)
21 days - Nugent Care 2019
20 days - Industry AVG
Creditor Days
its suppliers are paid after 25 days, this is slower than average (18 days)
25 days - Nugent Care 2019
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Nugent Care 2019
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 36 weeks, this is less cash available to meet short term requirements (127 weeks)
36 weeks - Nugent Care 2019
127 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 12.1%, this is a lower level of debt than the average (22.3%)
12.1% - Nugent Care 2019
22.3% - Industry AVG
NUGENT CARE 2019 financials
Nugent Care 2019's latest turnover from March 2024 is £21.6 million and the company has net assets of £14.4 million. According to their latest financial statements, Nugent Care 2019 has 483 employees and maintains cash reserves of £1.4 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | |
|---|---|---|---|---|---|
| Turnover | 21,596,000 | 17,245,000 | 15,650,000 | 17,425,000 | 17,466,000 |
| Other Income Or Grants | |||||
| Cost Of Sales | |||||
| Gross Profit | |||||
| Admin Expenses | |||||
| Operating Profit | |||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 1,104,000 | -541,000 | -35,000 | -2,086,000 | -3,536,000 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 1,104,000 | -541,000 | -35,000 | -2,086,000 | -3,536,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 1,104,000 | -541,000 | -35,000 | -2,086,000 | -3,536,000 |
| Employee Costs | 12,452,000 | 10,868,000 | 10,505,000 | 12,949,000 | 13,687,000 |
| Number Of Employees | 483 | 451 | 418 | 507 | 587 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | |
|---|---|---|---|---|---|
| Tangible Assets | 7,445,000 | 6,676,000 | 6,218,000 | 9,274,000 | 10,358,000 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 5,637,000 | 5,340,000 | 5,537,000 | 5,197,000 | 4,429,000 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 13,082,000 | 12,016,000 | 11,755,000 | 14,471,000 | 14,787,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 1,259,000 | 1,692,000 | 1,075,000 | 1,782,000 | 1,881,000 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 613,000 | 448,000 | 349,000 | 323,000 | 454,000 |
| Cash | 1,398,000 | 314,000 | 1,745,000 | 713,000 | 547,000 |
| misc current assets | 0 | 0 | 0 | 0 | 19,000 |
| total current assets | 3,270,000 | 2,454,000 | 3,169,000 | 2,818,000 | 2,901,000 |
| total assets | 16,352,000 | 14,470,000 | 14,924,000 | 17,289,000 | 17,688,000 |
| Bank overdraft | 0 | 87,000 | 127,000 | 2,374,000 | 105,000 |
| Bank loan | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 926,000 | 761,000 | 266,000 | 359,000 | 791,000 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 1,055,000 | 795,000 | 880,000 | 1,082,000 | 1,219,000 |
| total current liabilities | 1,981,000 | 1,643,000 | 1,273,000 | 3,815,000 | 2,115,000 |
| loans | 0 | 0 | 86,000 | 213,000 | 294,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 86,000 | 213,000 | 294,000 |
| total liabilities | 1,981,000 | 1,643,000 | 1,359,000 | 4,028,000 | 2,409,000 |
| net assets | 14,371,000 | 12,827,000 | 13,565,000 | 13,261,000 | 15,279,000 |
| total shareholders funds | 14,371,000 | 12,827,000 | 13,565,000 | 13,261,000 | 15,279,000 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Operating Profit | |||||
| Depreciation | 773,000 | 621,000 | 635,000 | 713,000 | 639,000 |
| Amortisation | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 |
| Debtors | -268,000 | 716,000 | -681,000 | -230,000 | 2,335,000 |
| Creditors | 165,000 | 495,000 | -93,000 | -432,000 | 791,000 |
| Accruals and Deferred Income | 260,000 | -85,000 | -202,000 | -137,000 | 1,219,000 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||
| Investing Activities | |||||
| capital expenditure | 0 | 0 | 0 | 0 | 0 |
| Change in Investments | 297,000 | -197,000 | 340,000 | 768,000 | 4,429,000 |
| cash flow from investments | -297,000 | 197,000 | -340,000 | -768,000 | -4,429,000 |
| Financing Activities | |||||
| Bank loans | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | -86,000 | -127,000 | -81,000 | 294,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||
| interest | 0 | 0 | 0 | 0 | 0 |
| cash flow from financing | 440,000 | -283,000 | 212,000 | -13,000 | 19,109,000 |
| cash and cash equivalents | |||||
| cash | 1,084,000 | -1,431,000 | 1,032,000 | 166,000 | 547,000 |
| overdraft | -87,000 | -40,000 | -2,247,000 | 2,269,000 | 105,000 |
| change in cash | 1,171,000 | -1,391,000 | 3,279,000 | -2,103,000 | 442,000 |
nugent care 2019 Credit Report and Business Information
Nugent Care 2019 Competitor Analysis
Perform a competitor analysis for nugent care 2019 by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in L 7 area or any other competitors across 12 key performance metrics.
nugent care 2019 Ownership
NUGENT CARE 2019 group structure
Nugent Care 2019 has no subsidiary companies.
Ultimate parent company
NUGENT CARE 2019
12227571
nugent care 2019 directors
Nugent Care 2019 currently has 8 directors. The longest serving directors include Mr William Stead (Sep 2019) and Mr John-Paul Dennis (Sep 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr William Stead | 55 years | Sep 2019 | - | Director | |
| Mr John-Paul Dennis | United Kingdom | 45 years | Sep 2019 | - | Director |
| Reverend Michael Fitzsimons | England | 54 years | Sep 2019 | - | Director |
| Father Michael Fitzsimons | 54 years | Sep 2019 | - | Director | |
| Ms Sarah Johnson | 47 years | Sep 2019 | - | Director | |
| Reverend Paul Rooney | 58 years | Jun 2020 | - | Director | |
| Mr Jonathan Oliver | England | 31 years | Sep 2022 | - | Director |
| Mrs Wendy Bowyer | England | 40 years | Jun 2024 | - | Director |
P&L
March 2024turnover
21.6m
+25%
operating profit
1.4m
0%
gross margin
38.5%
+2.69%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
14.4m
+0.12%
total assets
16.4m
+0.13%
cash
1.4m
+3.45%
net assets
Total assets minus all liabilities
nugent care 2019 company details
company number
12227571
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
September 2019
age
6
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
MACINTYRE HUDSON LLP
address
99 edge lane, liverpool, merseyside, L7 2PE
Bank
HSBC BANK PLC
Legal Advisor
-
nugent care 2019 Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to nugent care 2019. Currently there are 1 open charges and 0 have been satisfied in the past.
nugent care 2019 Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for NUGENT CARE 2019. This can take several minutes, an email will notify you when this has completed.
nugent care 2019 Companies House Filings - See Documents
| date | description | view/download |
|---|
